Amrutanjan Health Care Crecimiento futuro
Future controles de criterios 0/6
Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Amrutanjan Health Care.
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Pharmaceuticals | 17.9% |
| Tasa de crecimiento de los ingresos | n/a |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | None |
| Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00
Nov 19
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 17We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings
May 31Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Amrutanjan Health Care no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.
Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 9/30/2024 | 4,378 | 475 | 181 | 249 | N/A |
| 6/30/2024 | 4,271 | 426 | N/A | N/A | N/A |
| 3/31/2024 | 4,214 | 450 | 212 | 279 | N/A |
| 12/31/2023 | 3,946 | 440 | N/A | N/A | N/A |
| 9/30/2023 | 3,753 | 373 | 300 | 364 | N/A |
| 6/30/2023 | 3,865 | 432 | N/A | N/A | N/A |
| 3/31/2023 | 3,798 | 398 | 113 | 202 | N/A |
| 12/31/2022 | 3,860 | 418 | N/A | N/A | N/A |
| 9/30/2022 | 3,990 | 517 | 112 | 337 | N/A |
| 6/30/2022 | 3,986 | 588 | N/A | N/A | N/A |
| 3/31/2022 | 4,059 | 672 | 287 | 522 | N/A |
| 12/31/2021 | 3,935 | 627 | N/A | N/A | N/A |
| 9/30/2021 | 3,829 | 631 | 368 | 457 | N/A |
| 6/30/2021 | 3,644 | 668 | N/A | N/A | N/A |
| 3/31/2021 | 3,330 | 612 | 889 | 909 | N/A |
| 12/31/2020 | 2,984 | 589 | N/A | N/A | N/A |
| 9/30/2020 | 2,811 | 474 | 744 | 754 | N/A |
| 6/30/2020 | 2,635 | 322 | N/A | N/A | N/A |
| 3/31/2020 | 2,617 | 251 | 156 | 182 | N/A |
| 12/31/2019 | 2,876 | 314 | N/A | N/A | N/A |
| 9/30/2019 | 2,751 | 274 | N/A | N/A | N/A |
| 6/30/2019 | 2,621 | 257 | N/A | N/A | N/A |
| 3/31/2019 | 2,535 | 250 | 191 | 212 | N/A |
| 12/31/2018 | 2,406 | 158 | N/A | N/A | N/A |
| 9/30/2018 | 2,335 | 168 | N/A | N/A | N/A |
| 6/30/2018 | 2,288 | 201 | N/A | N/A | N/A |
| 3/31/2018 | 2,203 | 200 | N/A | 191 | N/A |
| 12/31/2017 | 2,247 | 165 | N/A | N/A | N/A |
| 3/31/2017 | 2,240 | 211 | N/A | N/A | N/A |
| 3/31/2016 | 1,867 | 206 | N/A | 207 | N/A |
| 3/31/2015 | 1,666 | 149 | N/A | 183 | N/A |
| 3/31/2014 | 1,417 | 124 | N/A | 174 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de AMRUTANJAN es superior a la tasa de ahorro (6.7%).
Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de AMRUTANJAN crezcan más rápidamente que el mercado Indian
Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de AMRUTANJAN crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de AMRUTANJAN crezcan más rápidamente que el mercado de Indian.
Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de AMRUTANJAN crezcan a un ritmo superior a 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de AMRUTANJAN se prevé que sea elevada dentro de 3 años.